Insights into the pathogenesis of normal-pressure hydrocephalus
Document Type
Editorial
Publication Title
Neurology
ISSN
1526-632X
Volume
92
Issue
20
First Page
933
Last Page
934
PubMed ID
31004073
Publisher
Lippincott Williams and Wilkins
School
School of Medical and Health Sciences
Abstract
Normal-pressure hydrocephalus (NPH) is a poorly defined clinical syndrome, classically characterized by the phenotypic triad of gait instability, cognitive impairment, and urinary incontinence, accompanied by neuroimaging evidence of ventriculomegaly and disproportionally enlarged subarachnoid space hydrocephalus and normal intracranial pressure.1,2 The diagnosis of this syndrome is complex since the characterizing symptoms are highly nonspecific and occur together in fewer than two thirds of NPH patients. In addition, a growing body of evidence supports the observation that NPH patients often have a coexistent neurodegenerative disorder that may be a concurrent or sole cause of both clinical symptoms and ventriculomegaly. This may be the main cause for the short-lived benefits secondary to an NPH-targeted therapeutic intervention, such as the placement of a ventriculoperitoneal shunt.2
DOI
10.1212/WNL.0000000000007495
Access Rights
subscription content
Comments
Spina, S., & Laws, S. M. (2019). Insights into the pathogenesis of normal-pressure hydrocephalus. Neurology, 92(20), 933-934. Available here